ZA200705782B - Meta-substituted thiazolidinones, the production thereof and their use as medicaments - Google Patents

Meta-substituted thiazolidinones, the production thereof and their use as medicaments

Info

Publication number
ZA200705782B
ZA200705782B ZA200705782A ZA200705782A ZA200705782B ZA 200705782 B ZA200705782 B ZA 200705782B ZA 200705782 A ZA200705782 A ZA 200705782A ZA 200705782 A ZA200705782 A ZA 200705782A ZA 200705782 B ZA200705782 B ZA 200705782B
Authority
ZA
South Africa
Prior art keywords
medicaments
meta
production
substituted thiazolidinones
thiazolidinones
Prior art date
Application number
ZA200705782A
Inventor
Schulze Volker Klaus
Wortmann Lars
Prien Olaf
Hess-Stumpp Holger
Dominic E A Brittain
Eis Knut
Kosemund Dirk
Siemeister Gerhard
Eberspaecher Uwe
Islam Imadul
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200705782B publication Critical patent/ZA200705782B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200705782A 2004-12-15 2007-07-13 Meta-substituted thiazolidinones, the production thereof and their use as medicaments ZA200705782B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004061503A DE102004061503A1 (en) 2004-12-15 2004-12-15 New meta-substituted thiazolidinone compounds are polo-like kinase inhibitors useful to treat cancers, autoimmune-, cardiovascular-, infectious-, nephrological-, nephrological- and neurodegenerative-diseases

Publications (1)

Publication Number Publication Date
ZA200705782B true ZA200705782B (en) 2009-09-30

Family

ID=36580263

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705782A ZA200705782B (en) 2004-12-15 2007-07-13 Meta-substituted thiazolidinones, the production thereof and their use as medicaments

Country Status (3)

Country Link
CN (1) CN101146782A (en)
DE (1) DE102004061503A1 (en)
ZA (1) ZA200705782B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2065039A1 (en) 2007-11-27 2009-06-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Selective inhibition of Polo-like kinase 1
CN104402830A (en) * 2014-11-27 2015-03-11 太仓运通生物化工有限公司 Synthesis method of 2-chloropyrimidine
CN114907288B (en) * 2022-05-13 2023-12-08 中国医学科学院医药生物技术研究所 Application of nitrobenzene compounds in preparation of pseudomonas aeruginosa quorum sensing inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2004135533A (en) * 2002-05-03 2005-07-20 Шеринг Акциенгезельшафт (De) THIAZOLIDINONES AND THEIR APPLICATION AS POLO-LIKE KINASE INHIBITORS
DE10351744A1 (en) * 2003-10-31 2005-06-16 Schering Ag Thiazolidinones, their preparation and use as pharmaceuticals

Also Published As

Publication number Publication date
CN101146782A (en) 2008-03-19
DE102004061503A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
IL183395A0 (en) Meta-substituted thiazolidinones, the production thereof and their use as medicaments
IL179170A0 (en) Novel substituted thiophenecarboxamides, their production and their use as medicaments
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
IL178334A0 (en) Selected cgrp antagonists, methods for the production thereof and their use as medicaments
IL181964A0 (en) Medicaments comprising carbonyl compounds, and the use thereof
IL185381A0 (en) Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
IL180874A0 (en) Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
IL184694A0 (en) New polymorphous forms of rifazimin, processes for their production and use thereof in the medicinal
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
PL1673352T3 (en) Sulfoximine-substituted pyrimidines for use as cd and/or vegf-inhibitors, the production thereof and their use as drugs
IL186090A0 (en) Cgrp antagonists, method for the production thereof, and their use as medicaments
IL179758A0 (en) Substituted tetrahydro - 2h - isoquinolin - 1 - one derivatives, method for the production thereof, and use of the same as medicaments
IL190423A0 (en) Selected cgrp antagonists , methods for the production thereof and their use as medicaments
IL184526A0 (en) Substituted aminomethylene sulphonamides, production and use thereof as medicaments
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
IL189497A0 (en) Selected cgrp antagonists, methods for the production thereof and their use as medicaments
IL178259A0 (en) Novel benzothiazoles and the use thereof as medicaments
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
ZA200710146B (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
ZA200705782B (en) Meta-substituted thiazolidinones, the production thereof and their use as medicaments
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents